Genome-wide association study identifies genetic variants which predict the response of bone mineral density to teriparatide therapy

Nerea Alonso, Omar M E Albagha, Asim Azfer, Beatriz Larraz Prieto, Kathryn Berg, Philip Riches, Barbara Ostanek, Tomaz Kocjan, Janja Marc, Bente L. Langdahl, Stuart H Ralston*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Objectives Teriparatide (TPTD) is an effective treatment for osteoporosis but the individual response to therapy is variable for reasons that are unclear. This study aimed to determine whether the response to TPTD might be influenced by genetic factors.

Methods We searched for predictors of the response of bone mineral density (BMD) to TPTD using a two-stage genome-wide association study in 437 patients with osteoporosis from three referral centres. Demographic and clinical data including the response of BMD to treatment at the lumbar spine and hip were extracted from the medical records of each participant.

Results Allelic variation at rs6430612 on chromosome 2, close to the CXCR4 gene was associated with the response of spine BMD to TPTD at a genome wide significant level (p=9.2×10−9 beta=−0.35 (−0.47 to −0.23)). The increase in BMD was almost twice as great in AA homozygotes at rs6430612 as compared with GG homozygotes with intermediate values in heterozygotes. The same variant was also associated with response of femoral neck and total hip BMD (p=0.007). An additional locus on chromosome 19 tagged by rs73056959 was associated with the response of femoral neck BMD to TPTD (p=3.5×10−9, beta=−1.61 (−2.14 to −1.07)).

Conclusions Genetic factors influence the response to TPTD at the lumbar spine and hip with a magnitude of effect that is clinically relevant. Further studies are required to identify the causal genetic variants and underlying mechanisms as well as to explore how genetic testing for these variants might be implemented in clinical practice.
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Early online date20 Mar 2023
Publication statusE-pub ahead of print - 20 Mar 2023

Fingerprint

Dive into the research topics of 'Genome-wide association study identifies genetic variants which predict the response of bone mineral density to teriparatide therapy'. Together they form a unique fingerprint.

Cite this